Kirk A. Davis - 14 Aug 2023 Form 4 Insider Report for HARTE HANKS INC (HHS)

Reporting relationship: Chief Executive Officer, Director
Issuer ticker: HHS
Reported as of: 14 Aug 2023
Net transaction value: $0
SEC form: 4
Accepted by SEC: 15 Aug 2023, 17:27:56 UTC
Prior SEC filing: 15 Aug 2023
Next SEC filing: 16 Aug 2023
Source filing: View source filing
Reporting owner signature: /s/ Laurilee Kearnes, Attorney-in-Fact for Kirk A. Davis

Key filing fact

Kirk A. Davis filed Form 4 for HARTE HANKS INC (HHS) on 15 Aug 2023.

Key facts

This page summarizes Kirk A. Davis's Form 4 filing for HARTE HANKS INC (HHS).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 15 Aug 2023, 17:27.

Change

Previous filing in this sequence was filed on 15 Aug 2023.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

HHS transaction Derivative

Options

Award

Transaction value: $0
Shares: +240,000
Change %
Price: $0.000000
Shares after: 240,000
Date: 14 Aug 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 240,000
Exercise price: $5.59
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Options granted under the Harte Hanks, Inc. 2023 Inducement Equity Incentive Plan. The options vest and become exercisable as to 1/3rd of the underlying shares on each of the first three anniversaries of June 19, 2023.